Join our mailing list to receive the latest updates and alerts Flag Subscribe

Fredrikson & Byron acted as legal counsel for Techne Corporation (NASDAQ:TECH), d/b/a Bio-Techne, a company engaged in the development, manufacture and sale of biotechnology products and clinical calibrators and controls, in its $10 million equity investment in CyVek, Inc. (CyVek), which Bio-Techne has agreed to acquire if certain future milestones are met. CyVek is a privately funded biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The investment closed on April 4, 2014. Fredrikson’s legal team included Alexander Rosenstein, Andrew M. Nick, Amanda L. Welters and Lori P. Cobb.

Jump to Page

Fredrikson & Byron, P.A. stores cookies on your device to enhance site navigation, make your browsing experience as useful as possible, and analyze site usage. By accessing this website with cookies enabled in your web browser, you agree to the storing of cookies on your device. Please read our Privacy Policy and our Disclaimer.